13F-HR filed by Rafferty Asset Management, LLC
Rafferty Asset Management, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-10, with 1,007 holding rows worth $10,233,112,000.
- Accession
- 0001387131-21-001970
- Filer
- CIK 1389426
- Filed
- 2021-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A combination report, 1,007 entries on the cover page, a total value of $10,233,112,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $10,233,112,000 with VALUE read as thousands by filing date, 13F file number 028-12221. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerHilton Capital Management, LLC028-14787
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FORD MTR CO COM | 345370860 | Stock | 14,331 | $126,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 16,707 | $109,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 16,476 | $107,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 17,061 | $98,000 | thousands by filing date | |
| COLONY CAPITAL INC | 19626G108 | CL A COM | 17,316 | $83,000 | thousands by filing date | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 17,323 | $79,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 11,146 | $47,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-21-001970 | this filing | 2021-02-10 | acceptance time not in the bulk data set |